Compare T Rowe Price Group Inc (TROW) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T Rowe Price Group Inc vs 22nd Century Group Inc — how do they compare? T Rowe Price Group Inc trades at $115.59 (market cap $25.14B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: T Rowe Price Group Inc is far larger — about 16872.5× 22nd Century Group Inc's market cap, and T Rowe Price Group Inc pays a 4.43% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| TROW | XXII | |
|---|---|---|
Market Cap | $25.14B | $1.49M |
Sector | Financials | Technology |
52-Week High | $120.16 | $1.07K |
52-Week Low | $86.19 | $3.90 |
Enterprise Value | $21.85B | -$6.74M |
Dividend Yield | 4.43% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About T Rowe Price Group Inc
T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
